Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(3 sites)

United States

Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama

Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington